HCV Kinetic Models and Their Implications in Drug Development
about
Modelling hepatitis C therapy--predicting effects of treatmentEbola Virus Infection: Review of the Pharmacokinetic and Pharmacodynamic Properties of Drugs Considered for Testing in Human Efficacy Trials.The paradox of highly effective sofosbuvir-based combination therapy despite slow viral decline: can we still rely on viral kinetics?Individual Bayesian Information Matrix for Predicting Estimation Error and Shrinkage of Individual Parameters Accounting for Data Below the Limit of Quantification.
P2860
HCV Kinetic Models and Their Implications in Drug Development
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
HCV Kinetic Models and Their Implications in Drug Development
@ast
HCV Kinetic Models and Their Implications in Drug Development
@en
HCV Kinetic Models and Their Implications in Drug Development
@nl
type
label
HCV Kinetic Models and Their Implications in Drug Development
@ast
HCV Kinetic Models and Their Implications in Drug Development
@en
HCV Kinetic Models and Their Implications in Drug Development
@nl
prefLabel
HCV Kinetic Models and Their Implications in Drug Development
@ast
HCV Kinetic Models and Their Implications in Drug Development
@en
HCV Kinetic Models and Their Implications in Drug Development
@nl
P2860
P356
P1476
HCV Kinetic Models and Their Implications in Drug Development
@en
P2093
P2860
P304
P356
10.1002/PSP4.28
P407
P577
2015-04-01T00:00:00Z